CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 105 filers reported holding CLOVIS ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $96,000 | +11.6% | 80,284 | +68.2% | 0.00% | – |
| Q2 2022 | $86,000 | -59.8% | 47,738 | -54.9% | 0.00% | – |
| Q1 2022 | $214,000 | -50.2% | 105,886 | -33.2% | 0.00% | – |
| Q4 2021 | $430,000 | -48.7% | 158,515 | -15.7% | 0.00% | – |
| Q3 2021 | $839,000 | -18.3% | 188,042 | +6.2% | 0.00% | – |
| Q2 2021 | $1,027,000 | +29.8% | 177,145 | +57.1% | 0.00% | – |
| Q1 2021 | $791,000 | -33.1% | 112,773 | -54.3% | 0.00% | – |
| Q4 2020 | $1,183,000 | -2.5% | 246,526 | +18.5% | 0.00% | – |
| Q3 2020 | $1,213,000 | -16.3% | 208,028 | -3.1% | 0.00% | – |
| Q2 2020 | $1,449,000 | +202.5% | 214,707 | +185.7% | 0.00% | – |
| Q1 2020 | $479,000 | -43.4% | 75,141 | -7.4% | 0.00% | – |
| Q4 2019 | $846,000 | +269.4% | 81,168 | +39.4% | 0.00% | – |
| Q3 2019 | $229,000 | -69.9% | 58,237 | +13.9% | 0.00% | – |
| Q2 2019 | $760,000 | -33.2% | 51,108 | +11.6% | 0.00% | – |
| Q1 2019 | $1,137,000 | +87.9% | 45,808 | -8.1% | 0.00% | – |
| Q4 2018 | $605,000 | -30.5% | 49,860 | +10.1% | 0.00% | – |
| Q3 2018 | $870,000 | -88.2% | 45,277 | -72.1% | 0.00% | -100.0% |
| Q2 2018 | $7,380,000 | -37.1% | 162,286 | -27.0% | 0.00% | -33.3% |
| Q1 2018 | $11,734,000 | -33.8% | 222,260 | -14.7% | 0.00% | -40.0% |
| Q4 2017 | $17,720,000 | -21.3% | 260,592 | -4.6% | 0.01% | -28.6% |
| Q3 2017 | $22,503,000 | +3.5% | 273,094 | +17.6% | 0.01% | 0.0% |
| Q2 2017 | $21,748,000 | +23.4% | 232,270 | -16.1% | 0.01% | +16.7% |
| Q1 2017 | $17,630,000 | +878.9% | 276,898 | +583.0% | 0.01% | +500.0% |
| Q4 2016 | $1,801,000 | +173.7% | 40,543 | +122.4% | 0.00% | – |
| Q3 2016 | $658,000 | +219.4% | 18,232 | +21.2% | 0.00% | – |
| Q2 2016 | $206,000 | -13.1% | 15,037 | +21.7% | 0.00% | – |
| Q1 2016 | $237,000 | -72.6% | 12,356 | -69.6% | 0.00% | – |
| Q4 2015 | $864,000 | -98.5% | 40,677 | -93.6% | 0.00% | -100.0% |
| Q3 2015 | $58,447,000 | +2184.9% | 635,574 | +2083.4% | 0.02% | +2300.0% |
| Q2 2015 | $2,558,000 | -35.2% | 29,110 | -45.3% | 0.00% | 0.0% |
| Q1 2015 | $3,950,000 | +550.7% | 53,192 | +390.8% | 0.00% | – |
| Q4 2014 | $607,000 | +49.1% | 10,837 | +20.7% | 0.00% | – |
| Q3 2014 | $407,000 | -29.7% | 8,978 | -35.8% | 0.00% | – |
| Q2 2014 | $579,000 | -55.3% | 13,988 | -25.2% | 0.00% | -100.0% |
| Q1 2014 | $1,295,000 | +77.9% | 18,693 | +54.6% | 0.00% | – |
| Q4 2013 | $728,000 | +4.7% | 12,092 | +5.7% | 0.00% | – |
| Q3 2013 | $695,000 | -19.1% | 11,440 | -10.8% | 0.00% | – |
| Q2 2013 | $859,000 | – | 12,824 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |